 |
|
|
|
|
Publications 2005
|
|
[ Latest publications ]
[ 2007 ]
[ 2006 ]
[ 2005 ]
[ 2004 ] |
List of publications 2005 from the Consortium.
Links to full articles when available. Some journals require subscription.
[ View
abstracts of some of the articles>> ]
|
|
|
Bach, S., Knockaert, M., Lozach, O.,
Reinhardt, J., Baratte, B., Schmitt, S., Coburn, S.P., Tang, L., Jiang. T.,
Liang, D.C., Galons, H., Dierick, J.F., Totzke, F., Schächtele, C., Lerman,
A.S., Carnero, A., Wan, Y., Gray, N. and Meijer, L.
Roscovitine targets: protein kinases and pyridoxal kinase.
J. Biol. Chem. 2005, 280, 31208-31219.
Abstract
>>
|
|
Bagossi, P., Horváth,
G., Vereb, G., Jr., Szöllősi,
J. & Tőzser,
J.
Molecular Modeling of Nearly Full-Length ErbB2 Receptor.
Biophys J. 2005, 88, 1354-1363.
Abstract >> |
|
|
|
Battistutta R., Mazzorana M., Sarno S., Kazimierczuk Z., Zanotti G. and
Pinna L. A. (2005)
Inspecting the structure-activity relationship of protein kinase CK2
inhibitors derived from tetrabromo-benzimidazole
Chemistry & Biol. 12, 1211-1219
http://www.sciencedirect.com >>
|
|
Belmont, P., Belhadj, T.
An Efficient and Simple Aminobenzannulation Reaction: Pyrrolidine as a
Trigger for the Synthesis of 1-Amino-Acridines.
Org. Lett. 2005, 7, 1793-1795.
Article available for subscription at:
http://pubs3.acs.org
|
|
|
|
Brańa, M.F., Cacho, M., García, M.L., Mayoral,
E.P., López, B., de Pascual-Teresa, B., Ramos, A., Acero, N., Llinares, F.,
Muńoz-Mingarro, D., Lozach, O. and Meijer, L.
Pyrazolo[3,4-c]pyridazines as novel and selective inhibitors of cyclin-dependent
kinases.
J. Med. Chem. 2005, 48, 6843-6854.
Pdf and supplementary material available at
www.sb-roscoff.fr
|
|
Bustos V. H. , Marin C., Meggio F., Cesaro L., Allende C. C. , Allende J.
E., and Pinna L. A. (2005)
Generation of protein kinase Ck1 alpha mutants which discriminate between
canonical and non-canonical substrates
Biochem. J. 391, 417-424. |
|
|
|
Coluccia, A. M., Gunby, R. H., Tartari,
C. J., Scapozza, L., Gambacorti-Passerini, C.,
and Passoni, L.
Anaplastic lymphoma kinase and its
signalling molecules as novel targets in
lymphoma therapy.
Expert Opin Ther
Targets, 2005, 9: 515-532.
Abstract >>
http://www.ashley-pub.com >>
|
|
Coluccia A.M.L., Benati D., Dekhil H., Lan C., Marchesi E.,
Gambacorti-Passerini C.
Inhibition of Src-mediated beta-Catenin tyrosine phosphorylation in
Colorectal cancer cells leads to decreased transcriptional activity and
induces a proliferation block.
Cancer Res., 2006, 66, 2279-86. |
|
|
|
Donella-Deana A., Marin O., Cesaro L., Gunby R.H., Ferrarese A., Tartari C.,
Mologni L., Scapozza L., Gambacorti-Passerini C., Pinna L.
Unique substrate specificity of Anaplastic Lymphoma Kinase (ALK):
development of phosphoacceptor peptides for the assay of ALK activity
Biochemistry, 2005, 44(23):8533-42.
Abstract
>>
|
|
Ferrari S., Marin O., Pagano M. A., Meggio F., Hess D., El-Shemerly M.,
Krystyniak A., and Pinna L. A. (2005)
Aurora-A
site specificity: a study with synthetic peptide substrates
Biochem. J. 390, 293-302.
Full
article>> |
|
|
|
Gambacorti-Passerini C.
Gene expression analysis fails to identify patients with chronic myeloid
leukemia who will achieve cytogenetic response to imatinib.
Haematologica 2005;90:434.
http://www.haematologica.org >>
|
|
Gambacorti-Passerini C., Gasser M., Hafedh S., Scapozza L.
BMS-354825 binding mode in Ableson kinase revealed by molecular docking
studies.
Leukemia, 2005, 19, 1267−1269.
Abstract >>
http://www.nature.com >> |
|
|
|
Gunby, R. H., Tartari, C. J.,
Porchia, F., Donella-Deana, A., Scapozza, L., and Gambacorti-Passerini,
C.
An
enzyme-linked immunosorbent assay to screen for
inhibitors of the oncogenic anaplastic lymphoma
kinase.
Haematologica, 2005,
90: 988-990.
Abstract >>
Pdf (112 KB) available for downloading at:
http://www.haematologica.org >>
|
|
Haider U.G., Roos T.U., Kontaridis M.I., Neel B.G., Sorescu D., Griendling K.K.,
Vollmar A.M., Dirsch V.M.
Resveratrol inhibits angiotensin II- and EGF-mediated Akt activation -
role of Gab1 and Shp2.
Mol Pharmacol. 2005 Apr 22;
Abstract >>
http://molpharm.aspetjournals.org >> |
|
|
|
Horváth, G., Petrás, M., Szentesi,
G., Fábián, Á., Park, J. W., Vereb, G., Jr. & Szöllősi,
J.
Selecting the right fluorophores and flow cytometer for fluorescence
resonance energy transfer measurements.
Cytometry A 2005, 62(2): 148-57
Abstract >>
http://www3.interscience.wiley.com >>
|
|
Kunick C., Zeng Z., Gussio R., Zaharevitz D.,
Leost M., Totzke F., Schächtele C., Kubbutat M. H. G., Meijer L., Lemcke T.
Structure-Aided Optimization of Kinase Inhibitors Derived from
Alsterpaullone
ChemBioChem, 2005, 6, 3, 541-549.
Abstract >>
http://www3.interscience.wiley.com >>
|
|
|
|
Di Maira G., Salvi M., Arrigoni G., Marin O., Sarno S., Brustolon F., Pinna
L. A., and Ruzzene M. (2005)
Protein kinase CK2 phosphorylates and upregulates Akt/PKB
Cell Death Diff. 12, 668-677.
http://www.nature.com >>
|
|
Mocanu, M., Fazekas, Z., Petrás, M., Nagy, P., Sebestyén, Z., Isola, J.,
Tímár, J., Park, J. W., Vereb, G., Jr. & Szöllősi,
J.
Associations of ErbB2, ß1-integrin and lipid rafts on Herceptin®
(Trastuzumab) resistant and sensitive tumor cell lines.
Cancer Letters. 2005, 227(2):201-212.
Abstract >>
Full article available at:
http://www.sciencedirect.com
|
|
|
|
Mologni L., Sala E., Riva B., Cesaro L., Cazzaniga S., Redaelli S., Marin O., Pasquato N., Donella-Deana A., Gambacorti-Passerini C.
Expression, purification and inhibition of human RET tyrosine kinase
Protein Expression & Purification, 2005, 41, 1, 177-185.
Abstract >>
http://www.sciencedirect.com >> |
|
Nagy, P., Bene, L., Hyun, W. C., Vereb, G., Jr., Braun, M., Antz, C., Paysan,
J.,., Damjanovich, S. Park, J. W & Szöllősi,
J.
Novel
calibration method for flow cytometric determination of fluorescence
resonance energy transfer efficiency between visible fluorescent proteins.
Cytometry A. 2005, 67(2): 86-96.
Abstract >>
Full
article available at:
http://www3.interscience.wiley.com
|
|
|
|
Pagano M. A., Sarno S., Poletto G., Cozza G., Pinna L. A., and Meggio F.
(2005)
Autophosphorylation
at the regulatory beta subunit reflects the supramolecular organization of
protein kinase CK2.
Mol. Cell. Biochem. 274, 23-29.
http://www.springerlink.com
|
|
Patin, A., Belmont, P.
A New Route to Acridines: Pauson-Khand Reaction on Quinoline-Bearing
1-En-7-ynes Leading to Novel Tetrahydrocyclopenta[c]acridine-2,5-diones.
Synthesis 2005, 2400-2406.
Abstract >>
Thieme-connect.com>>
|
|
|
|
Perseghin P,, Gambacorti-Passerini C., Tornaghi L., Dassi M., Pioltelli P.,
Parma M., Colnaghi F., Giudici G., Elli E., Fumagalli M., Ponchio L., Biondi
A., Pogliani E.
Peripheral blood stem cell collection in CML patients after treatment
with imatinib mesylate and complete cytogenetic response.
Transfusion 2005, 45, 1214-20.
Abstract >>
|
|
Piazza R., Magistroni V., Gasser M., Andreoni F., Galietta A., Scapozza L.,
Gambacorti-Passerini C.
Evidence for D276G and L364I Bcr-Abl mutations in Ph+ leukemic cells
obtained from patients resistant to Imatinib.
Leukemia 2005, 19, 132-134.
Read more >>
http://www.nature.com >>
[ Full article ] (Pdf, 161 KB)
|
|
|
|
Piazza R., Magistroni V., Andreoni F., Franceschino A., Tornaghi L., Varella-Garcia
M., Bungaro S., Colnaghi F., Corneo G., Pogliani E.M., Gambacorti-Passerini
C.
Imatinib dose increase up to 1200 mg daily can induce durable complete
cytogenetic remissions (CCR) in relapsed Ph+ chronic myeloid leukemia (CML)
patients.
Leukemia, 2005, 19, 1985–1987.
http://www.nature.com >>
|
|
Piazza R.G., Magistroni V., Franceschino A., Gambacorti-Passerini C.
‘D276G mutation is associated with a poor prognosis in imatinib
mesylate-resistant chronic myeloid leukemia patients'. Response to Leguay et
al.
Leukemia 19, 2005, 2333-2334.
http://www.nature.com >>
|
|
|
|
Sarno S., Salvi M., Battistutta R., Zanotti G., and Pinna L. A. (2005)
Features and potentials of ATP-site directed CK2 inhibitors
Biochim. Biophys. Acta – Proteins and Proteomics 1754, 263-270.
http://www.sciencedirect.com >>
|
|
Sarno S., Ruzzene M., Frascella P., Pagano M. A., Meggio F., Zambon A.,
Mazzorana M., Di Maira G., Lucchini V., and Pinna L. A. (2005)
Development
and exploitation of CK2 inhibitors
Mol. Cell. Biochem. 274, 69-76.
http://www.springerlink.com>> |
|
|
|
Tang, L., Li, M.H., Cao, P., Wang, F., Chang,
W.R., Bach, S., Reinhardt, J., Koken, M., Galons, H., Wan, Y., Gray, N.,
Meijer, L., Jiang. T. and Liang, D.C.
Crystal structure of pyridoxal kinase in complex with roscovitine and
derivatives.
J. Biol. Chem. 2005, 280, 31220-31229.
Abstract
>>
|
|
Wu, Z.L., Aryal, P., Lozach, O., Meijer, L.
and Guengerich, F.P..
Biosynthesis of new indigoid inhibitors of protein kinases using
recombinant cytochrome P450 2A6.
Chem. & Biodiv. 2005, 2, 51-65.
Pdf available at
www.sb-roscoff.fr |
|
|
|
Xie X, Lemcke T, Gussio R, Zaharevitz D W, Leost M, Meijer L, Kunick C.
Epoxide-containing side chains enhance antiproliferative activity of
paullones.
Eur. J. Med. Chem. 2005, 40, 655-661.
Abstract >>
http://www.sciencedirect.com >>
|
|
|
|
Updated 24 July 2008
webmaster (at) proteinkinase-research.org
|
|